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OBJECTIVES
The aim of this work is to engineer a bacterio-
phage-based platform to specifically target, invade 
and control cancer.
WORK PLAN
Firstly, a targeted drug-carrying bacteriophage will be 
constructed. Genetic manipulation to endow phages 
with cancer-specificity-conferring ligands, as well as 
chemical conjugation to load the targeted phages 
with cytotoxic drugs will be performed. Secondly, 
novel ligand peptides will be screened and selected 
to inhibit cell proliferation and induce cell death when 
coupled with drug-carrying phages. Phage display 
and iPhage technology to screen surface- and inter-
nalizing-peptide libraries will be applied. Thirdly, a 
phage-based gene therapy approach will be devel-
oped to regulate cancer proliferation and metastasis. 
Specifically, phages will carry zinc finger nucleases 
specific for mammalian target of rapamycin (mTOR) 
and ribosomal S6 kinase (RSK) pathways. Fourthly, 
the effect of temperature will be studied to induce 
modifications of portal and protein capsid conforma-
tion on phages, triggering nanoparticle disassembly 
and cargo delivery. Finally, the mechanisms under-
lying internalization and trafficking of engineered 
phages will be elucidated.
RESULTS
Using molecular biology tools a filamentous phage, 
M13KE, was engineered to display a target-specific 
(231 peptide) and cell-penetrating peptides (Pene-
tratin and TAT-HIV) in the pIII minor capsid protein 
in order to promote specific internalization, thereby 
facilitating the direct delivery of the drug. Engi-
neered phages were conjugated with doxorubicin, 
an anti-carcinogenic drug, and incubated with breast 
cancer (MDA-MB-231) and breast epithelium (MCF-
10-2A) cell lines to evaluate internalization of phage 
particles and cytotoxicity. Up to now, there are good 
indicators that drug-carrying phages equipped with 
specific peptides for cancer cells can be specifically 
internalized promoting cell death.
Acknowledgement: The author acknowledges the Lipid’NP’Phage 
project team (PTDC/SAU-BMA/121028/2010) for support given in 
the laboratory.
Rational design of bacteriophages as 
a platform for cancer therapy
Tânia Mendes
MIT Portugal Bioengineering Systems, Centre of Biological Engineering, University of Minho
taniamendes@ceb.uminho.pt
Background: MSc in Biological Engineering/ School of Engineering, Department of Biological Engineering,
 University of Minho / Portugal
Starting year: 2012
Supervisors: Lígia Rodrigues1; Leon Kluskens1
 1Centre of Biological Engineering, University of Minho
